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Abstract
Background: Self-hypnosis has been taught routinely at the SUNY Upstate Medical University for
treatment of pulmonary symptoms thought to be amenable to psychological therapy. While using
hypnosis for relaxation, four individuals, including a patient with cystic fibrosis, reported
development of blue-tinted vision. Based on a search of the literature, we believe this is the first
published report of hypnosis-associated blue-tinted vision.
Case presentation: The patient reported blue-tinted vision when he used hypnosis on an almost
daily basis for seven years. The visual change typically occurred when he was relaxed. Moreover, a
concurrent erection in the absence of sexual thoughts usually was present. The other three
individuals reported blue-tinted vision after learning how to use hypnosis for relaxation as part of
a group hypnosis instruction.
Conclusion: The blue-tinted vision experienced by the individuals in this report may be the result
of an hypnosis-induced primary change in cognitive processing. Additionally, as the relaxing effect
of hypnosis can be associated with a reduction in blood pressure and increased blood flow,
hypnosis-associated blue-tinted vision also may be related to retinal vasodilation.
Background
Self-hypnosis has been taught routinely at the SUNY
Upstate Medical University Pediatric Pulmonary Center
for treatment of pulmonary symptoms thought to be ame-
nable to psychological therapy [1]. Patients who have
benefited from hypnosis instruction include those with
asthma, cystic fibrosis (CF), habit cough, shortness of
breath, and vocal cord dysfunction [1,2].
Our understanding of the nature of hypnosis is contested,
and rapidly evolving [1]. In practice, hypnosis can be
defined as an altered state of consciousness during which
a therapeutic goal can be achieved as a result of sugges-
tions made by a therapist or self-suggestions given by a
patient [1]. The state of hypnosis is a natural mental state
that can be achieved, for example, by children engaged in
imaginary play, or when students become bored and
imagine themselves engaged in an activity elsewhere.
After being taught to use hypnosis for relaxation by a phy-
sician from our Center, four individuals, including a
patient with CF, reported development of blue-tinted
vision. Based on a search of the literature, we believe this
is the first published report of hypnosis-associated blue-
tinted vision.
Case presentation
The patient was a 15-year-old with mild CF who was non-
adherent to his prescribed therapies. As a result of this
behavior, he developed shortness of breath and abdomi-
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nal discomfort. His prescribed medications included pan-
creatic enzymes, a multivitamin, an antacid, long and
short-acting bronchodilators by metered dose inhalers, a
corticosteroid by metered dose inhaler, and a mucolytic
medication by nebulization. The patient was supposed to
undergo daily mechanical chest physiotherapy. In order
to maintain his weight, he was supposed to eat a diet con-
sisting of at least 3500 kcal/day.
The patient was the second of six children. His youngest
sister had CF as well, while the other siblings were
healthy. He lived with both parents. When he was asked
why he had difficulties adhering to his therapies, he stated
that he was frustrated by his family's poor financial situa-
tion and insufficient supervision for the children.
On physical examination, he appeared small for his stated
age, but in no distress. His height was 149 cm (below the
3rd percentile for age, and at the 50th percentile for a 12-
year-old), and his weight was 35 kg (below the 3rd percen-
tile for age, and at the 50th percentile for an 11-year-old).
His head, eyes, ears, nose, and throat examination was
normal. His lungs were clear to auscultation. There was no
murmur on cardiac examination. His abdominal exami-
nation revealed no organomegaly or tenderness. His
pubic hair was at Tanner stage II. He had 3+ digital club-
bing.
The patient wondered whether use of self-hypnosis might
help him become more adherent to his therapies, as he
was aware that hypnosis was used widely by patients at his
Cystic Fibrosis Center [3]. He was told that he could use
hypnosis as a tool to become more adherent if that is what
he wished. The patient did not undergo testing for hypno-
tizability.
He was taught two induction techniques as a demonstra-
tion of how imagery in the mind could affect his body. He
learned how to imagine his hands as two giant magnets
that attracted each other, and noted how his hands came
together, apparently "on their own." He imagined hold-
ing a pail full of sand in one hand, while holding helium
balloons in the other hand. Within 15 seconds, one hand
fell slowly to his lap and the other hand levitated. The
patient stated it felt as if his hands had moved of their own
accord.
He then was instructed in how to use imagery in order to
relax. He learned to imagine going to a relaxing place,
which he picked as being in his bedroom. He imagined
what he might have perceived with each of his senses
there. He relaxed his muscles progressively from head to
toe. He picked the triggering gesture of touching his right
index finger to his right thumb that would remind him
how to relax even when he is not in hypnosis. When he
alerted, he stated that the hypnotic experience made him
feel as if he was really in his bedroom. When he made his
triggering gesture, he appeared visibly more relaxed and
said he was very pleased with his hypnotic abilities.
The patient was asked to which of his therapies he wanted
to adhere better. He replied that he wished he could
remember to take his pancreatic enzymes because other-
wise he might continue to develop abdominal discomfort.
He said he loved food. Therefore, it was suggested that he
imagine a shield in front of his mouth that would not
move in order to permit him to eat, unless he "unlocked"
the shield by taking his enzymes.
A month later, the patient reported taking his enzymes
regularly. Further, his adherence to the other therapies
also had improved. He had used self-hypnosis to rid him-
self of headaches by employing his triggering gesture. He
asked how he might use hypnosis to help himself feel bet-
ter. It was suggested that he pass a healing light through
himself when he did hypnosis. He used this imagery, and
when he alerted he reported noting a bluish tint to his
vision.
For the subsequent seven years, and continuing at this
time, the patient used self-hypnosis on an almost daily
basis. He has utilized it to relax, resolve headaches and
stomachaches, achieve complete analgesia in his extremi-
ties while undergoing medical procedures, reinforce his
adherence to his therapies, and to plan his daily activities.
Also, he used the hypnotic technique of automatic word
processing [4] to express his feelings about the challenges
of having a terminal disease. He developed a long-term
successful sexual relationship with a girl during these
years.
When queried about the blue tint of his vision, the patient
reported that the phenomenon continued to occur
approximately half of the time when he used hypnosis,
typically when he was very relaxed. He reported that the
visual change caused him to perceive imagery with a blue
background while he was in hypnosis. The blue-tinted
vision typically would persist for two to ten minutes fol-
lowing completion of an hypnosis session.
He said he had noted that whenever he developed blue-
tinted vision he also had a concurrent penile erection. He
said that he was surprised about the erection because he
was not having sexual thoughts. Also, he stated that his
erections were noticeable, because while the rest of his
body became very relaxed, he became very aware of the
sensations in his groin. Further, he reported that blue
became lighter in color when his erection became
stronger. He reported that on one occasion he remainedBMC Ophthalmology 2005, 5:28 http://www.biomedcentral.com/1471-2415/5/28
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in hypnosis for three hours. During this time his blue
vision "came and went", as did his erection.
The patient stated that he was unaware of reports regard-
ing the association of sildenafil and blue-tinted vision.
Further, the physician who taught the patient how to use
hypnosis, also was unaware of this association at the time
the patient first reported development of blue-tinted
vision.
The three other individuals who reported blue-tinted
vision in association with hypnosis, were part of a Califor-
nia group of 38 relatives of patients with CF, including
adolescents and adults, who did not know the patient
because he lived in New York. All 38 relatives were
instructed in use of hypnotic imagery to achieve relaxa-
tion, in the same manner as described for the patient. Fol-
lowing the 6-minute group hypnosis session, one of the
women reported spontaneously that her vision appeared
blue transiently following hypnosis. When the rest of the
group was queried, another woman stated that she also
had developed transient blue-tinted vision. A 17-year-old
boy stated that he had developed blue-tinted vision in the
past while doing hypnosis, which persisted for approxi-
mately 15 minutes following hypnosis. No group mem-
ber reported any other color or visual changes in
association with the hypnosis. Because of the group set-
ting, no inquiry was made regarding any other bodily
changes that might have been associated with the blue-
tinted vision.
Discussion
Studies have demonstrated that color perception in the
brain can be altered by imagery and suggestion in highly
hypnotizable subjects [5]. Other visual changes reported
to be inducible by hypnotic suggestion include develop-
ment of color blindness, tunnel vision, and visual halluci-
nations [6-10]. Further, it is thought that hypnosis can
improve a subject's subjective feeling of visual acuity by
improving other cognitive functions such as memory,
attention and perceptual learning [10]. Thus, the blue-
tinted vision experienced by the individuals in this report
may be the result of an hypnosis-induced primary change
in cognitive processing. Additionally, as visual changes
were not suggested and persisted after completion of hyp-
nosis, it is possible that the blue-tinted vision developed
as a result of hypnosis-induced retinal vasodilation medi-
ated through the autonomic nervous system [11-13]. Such
vasodilation may occur as a result of the known associa-
tion of hypnosis with a reduction in blood pressure and
increased blood flow [11-13].
Blue-tinted vision as a result of hypnosis may be similar in
nature to the blue-tinted vision that has been reported as
a rare side effect of sildenafil, a phosphodiesterase (PDE)
inhibitor [14]. Sildenafil has been demonstrated to
induce retinal vasodilation, perhaps as a result of PDE5
inhibition [15]. Hypnosis-associated changes in color per-
ception are unlikely to be related to visual disturbances
associated with digitalis toxicity (including development
of yellow vision) because the effect of digitalis is thought
to be caused by its inhibition of sodium-potassium ade-
nosine triphosphatase [16], which is unlikely to be
affected by hypnosis.
Hypnosis can be used as part of treatment for erectile dys-
function, by relaxation training, and suggestions aimed at
improvement of self-confidence [17,18]. While the
patient in this report did not suffer from erectile dysfunc-
tion, it is possible that his erections occurred because of
hypnosis-associated relaxation and improvement in self-
confidence. Additionally, the erections may have occurred
as a result of hypnosis-induced vasodilation of the arteri-
oles associated with the corpus cavernosum. This vasodi-
lation may be related to the effects of hypnosis on the
balance between the sacral parasympathetic and sympa-
thetic activity that is associated with the development of
penile erection [19]. Such vasodilation may be analogous
to that caused by sildenafil, which typically is used for
treatment of erectile dysfunction [14].
Sildenafil is thought to cause penile erections as a result of
vasodilation caused by PDE5 inhibition, while it is
believed to cause blue-tinted vision as a result of minor
inhibitory action against PDE6, an enzyme that resides
exclusively in retinal rod and cone receptors [20]. Since
sildenafil became available widely in 1998, other phos-
phodiesterase inhibitors have been introduced to treat
erectile dysfunction such as vardenafil and tadalafil. Silde-
nafil is 9 × more selective at inhibiting PDE5 than PDE6,
while vardenafil is 16 × more selective, and tadalafil is
1000 × more selective [14]. Altered color perception has
not been reported with use of vardenafil and tadalafil,
thereby supporting the idea that PDE6 inhibition leads to
development of blue-tinted vision [14]. On the other
hand, sildenafil has been available for widespread use for
much longer than tadalafil or vardenafil. Therefore, it is
possible that the rare side-effect of blue-tinted vision as a
result of PDE5 induced vasodilation has not yet been
observed with the newer phosphodiesterase inhibitors.
The described patient was successful at inducing vivid
imagery such as imagining that his bedroom appeared
"real". His ability to use a triggering gesture to return back
to the relaxed state demonstrated a good acceptance of a
post-hypnotic suggestion. Further, using hypnosis the
patient was able to achieve complete analgesia in his
extremities during medical procedures. Thus, he demon-
strated several traits characteristic of highly hypnotizable
children [21]. It is not known whether the other threePublish with BioMed Central    and   every 
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individuals reporting blue-tinted vision could have been
classified as highly hypnotizable. Therefore, it is unclear
whether development of blue-tinted vision typically
might be achieved only by individuals who are highly
hypnotizable.
Conclusion
The blue-tinted vision experienced by the individuals in
this report represents an anecdotal finding. Controlled
studies can help define whether blue-tinted vision occurs
as a result of an hypnosis-induced primary change in cog-
nitive processing or is related to retinal vasodilation, and
its relationship with hypnotic responsiveness of the sub-
jects. In order to gain a better understanding of this phe-
nomenon, affected individuals might be studied as well
through measures of retinal vasodilation.
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